1. The US FDA ‘Black Box’ Warning for Topical Calcineurin Inhibitors

   • Johannes Ring
   • Matthias Möhrenschlager
   • Verena Henkel

   Current Opinion 03 January 2013 Pages: 185 - 198

   

2. Drug-Induced Taste Disorders

   • Richard L. Doty
   • Muhammad Shah
   • Steven M. Bromley

   Review Article 03 January 2013 Pages: 199 - 215

   

3. A Benefit-Risk Review of Systemic Haemostatic Agents

   • Ian S. Fraser
   • Robert J. Porte
   • Andrea S. Lukes

   Review Article 03 January 2013 Pages: 217 - 230

   

4. Frequency and Clinical Relevance of Drug Interactions with Lovastatin and Simvastatin

   • Tuire Tirkkonen
   • Anna Ryynänen
   • Kari Laine

   Original Research Article 03 January 2013 Pages: 231 - 240

   

5. Post-Marketing Surveillance of Ischaemic Optic Neuropathy in Male Veterans Co-Prescribed Phosphodiesterase-5 Inhibitors with Organic Nitrates or α-Blockers

   • Dustin D. French
   • Curtis E. Margo

   Original Research Article 03 January 2013 Pages: 241 - 247

   

6. Improving the Detection of Subtle I_Kr-Inhibition

   • Jean-Philippe Couderc
   • Scott McNitt
   • Wojciech Zareba

   Original Research Article 03 January 2013 Pages: 249 - 260

   

7. Use of Over-the-Counter Analgesics in Patients with Chronic Liver Disease

   • Simona Rossi
   • David N. Assis
   • Victor J. Navarro

   Original Research Article 03 January 2013 Pages: 261 - 270

   

8. The ‘Power’ of Signal-Detection Algorithms

   • M. Rezaul Karim
   • Stephen L. Klincewicz
   • Chuen L. Yee

   Correspondence 03 January 2013 Pages: 271 - 272

9. The Authors’ Reply

   • Yasuyuki Matsushita
   • Yasufumi Kuroda
   • Isao Yoshimura

   Correspondence 03 January 2013 Pages: 272 - 273